Australia company Anatara Lifesciences is trialling the use of a bromelain-containing supplement in patients suffering from irritable bowel syndrome (IBS).
Malaysian firm Davos Life Science is interested to find out the efficacy of tocotrienols in alleviating the symptoms of irritable bowel syndrome (IBS) in humans, following a recent successful mice study.
A probiotic strain marketed by Lallemand Health Solutions has been granted new health claims related to Irritable Bowel Syndrome (IBS) by Canadian health authority Health Canada.
